Gsk upper merion

Author: s | 2025-04-24

GSK’s Upper Merion facility is located on the Upper Merion East Campus. GSK sold its Upper Merion West campus to The Discovery Labs, which announced in a J press release that it is redeveloping the Upper Merion West Campus and a campus in King of Prussia into a coworking ecosystem for healthcare, life sciences, and technology Upper Merion, Pennsylvania, United States GSK Upper Merion, Pennsylvania, United States Equity and Inclusion initiatives at GSK. She scaled programs of work, introduced them to other sites

GlaxoSmithKline (GSK) renovates Upper Merion and Upper

Home | Case Studies | GlaxoSmithKline (GSK) renovates Upper Merion and Upper Providence campuses The Challenge In an effort to modernize and renovate their existing facilities in Upper Merion and Upper Providence, GSK required a moving and storage vendor who could support the project which included: liquidating existing equipment, furniture, and fixtures; receiving, storing, delivering, and installing new equipment, furniture, and fixtures; and internally relocating employees into swing spaces and then back into their renovated space, totaling over 4,000 unique moves. The Solution Wayne Moving & Storage assigned project managers to each location to develop move schedules and plans to handle phased moves, with the largest phase move consisting of 800 total employees. Wayne also assigned additional personnel to a designated warehouse which would oversee the liquidation by auction of existing equipment and fixtures as well as receive and organize new product as it arrived. Wayne’s specialized Lab Teams worked with GSK scientists and OEM Service Technicians to ensure all items were prepped prior to relocation and properly placed and installed once received. The Result Wayne Moving & Storage minimized downtime to GSK’s operations by handling each lab separately, enabling teams at GSK to consistently have the lab space to handle their day-to-day operational needs. Wayne also minimized downtime to other employees by relocating them at night and with the help of ReloTech, disconnected and reconnected all employee PCs so that when they returned back to their workspace, they were able to work immediately without having to take the time to unpack and reconnect their PCs and peripherals. Developer J. Brian O’Neill, founder of the substance-abuse chain Recovery Centers of America, has paid $103.3 million to a partner to become the primary owner of a sprawling former pharmaceutical complex in Upper Merion once owned by GlaxoSmithKline.The deal, along with the planned purchase of The Philadelphia Inquirer’s printing plant in the area and the 2017 acquisition of offices from Liberty Property Trust, would give him control over 2.3 million square feet of real estate to pursue a long-held plan for a network of lab and office buildings occupied by a life-science tenants in western Montgomery County.O’Neill bought the roughly 1 million square feet of former GSK offices and labs on 128 acres in October 2020 from affiliates of hedge fund Beach Point Capital Management, his partner in owning the property since the fall of 2018, records show.The amount he paid the hedge fund was set three years ago in a buyout agreement struck when O’Neill teamed up with Beach Point to purchase the property from drug giant GlaxoSmithKline for $54 million, O’Neill said in an interview Monday.The acquisition last year by O’Neill’s MLP Ventures LLC was partially financed with a loan from another Beach Point unit, O’Neill said. The hedge fund is based in Santa Monica, Calif.MLP is continuing to plan for a cell- and gene-therapy manufacturing lab that would be partly located at the former drug complex, once part of GSK’s King of Prussia campus, O’Neill said.Other parts of the proposed facility — being marketed as the Center for Breakthrough Medicines — would be built in sections of the office park acquired three years ago from defunct developer Liberty Property Trust and at the Inquirer plant, O’Neill said.MLP and its partner on the proposed facility, private equity firm Deerfield Capital Management, have said the 680,000 square feet of cell-production lab space would cost $1.1 billion to develop. Deerfield, focused on health care, is also an investor in Recovery Centers of America.MLP began promoting its plans for the site in mid-2019, about nine months after the Beach Point-led group bought it. Its plan called for a campus for life-science tenants called Discovery Labs.Late last year, Gov. Tom Wolf’s administration approved a $1 million grant to build a parking garage there. The money would come from the Redevelopment Assistance Capital Program, a state fund for projects that might have a potentially outsized impact on economic development.Currently, the only tenants are GSK itself, which remained at the site as a lessee, and Wuxi Biologics, a Shanghai-area-based biotechnology company. Together, the two occupy 120,000 square feet of the 972,000-square-foot complex.Tenants of the office buildings acquired from Liberty include Children’s Hospital of Philadelphia, which manages its home-care program there; Thomas Jefferson University, which

Associate Scientist - Gsk - Upper Merion - WIZBII

Two GlaxoSmithKline scientists and three others were charged by a federal grand jury in Philadelphia on Wednesday with conspiracy to steal promising cancer research secrets from the pharmaceutical giant and market them to companies in China backed by the Chinese government.U.S. Attorney Zane David Memeger said Yu Xue, 45, of Wayne; Tao Li, 42, and Yan Mei, 36, both of Nanjing China; Tian Xue, 45, of Charlotte, N.C.; and Lucy Xi, 38, of West Lake Village, Calif., were named in the indictment.If convicted on all charges, each defendant faces possible prison terms, fines, restitution orders, and other penalties, Memeger said.Yu Xue was a senior-level manager at GSK's sprawling research lab in Upper Merion, where she clandestinely downloaded GSK trade secrets and confidential research data concerning the development of cancer-fighting monoclonal antibodies, according to the indictment.Yu Xue allegedly emailed information "potentially worth hundreds of millions of dollars or more" relating to a dozen or more products and drug development processes from her work email account to her personal email, and then forwarded the information to others in the conspiracy, according to an affidavit.The accused, according to the indictment, then formed a Delaware-based corporation, Renopharma, to eventually market the stolen trade secrets. One of Renopharma's major investors was the Chinese government, according to federal investigators. The conspirators allegedly used two China-based companies to assist in that scheme, Shanghai Renopharma and Nanjing Renopharma Ltd.GSK spokeswoman Sarah Spencer said that despite the criminal charges, the company remained confident that the alleged breach had no discernible impact on the company's business nor its research and development initiatives."We are aware of this issue and have been cooperating fully with the U.S. authorities," Spencer said. "While we're limited on what we can say about this ongoing investigation beyond the details in the indictment, we do not believe the breach has had any material impact on the company's business or R&D activity," she said.Yu Xue has hired Peter R. Zeidenberg as her lawyer. He formerly represented Temple University professor Xiaoxing Xi, an expert in superconductor research, who was cleared after federal prosecutors accused him of selling sensitive U.S. defense technology to the Chinese."Xue has pled not guilty and we'll be contesting these charges," Zeidenberg said. "It's one of many cases brought against Chinese Americans in the last several years, some of which have proved to be vastly overstated. I would just remind everybody that these are just allegations."Yu Xue is identified in the indictment as "one of the top protein biochemists in the world" with a doctoral degree in biological chemistry from the University of North Carolina.The world's major pharmaceutical companies have long wrung their hands about the theft of trade secrets in China and the unwillingness of Chinese authorities to protect the companies' intellectual property.The accused often sent emails to one another with news stories about scientists arrested at other drug companies for stealing trade secrets, according to court documents.The indictment alleges that Yu Xue and Lucy Xi, also a GSK scientist, had received training in the. GSK’s Upper Merion facility is located on the Upper Merion East Campus. GSK sold its Upper Merion West campus to The Discovery Labs, which announced in a J press release that it is redeveloping the Upper Merion West Campus and a campus in King of Prussia into a coworking ecosystem for healthcare, life sciences, and technology Upper Merion, Pennsylvania, United States GSK Upper Merion, Pennsylvania, United States Equity and Inclusion initiatives at GSK. She scaled programs of work, introduced them to other sites

Data Analyst / Engineer at GSK - Upper Merion

Lower Merion District was accused of snooping on students with school-issued laptop's webcam A suburban Pennsylvania school district accused of spying on students using school-issued laptops has agreed to pay $610,000 to settle litigation stemming from its controversial practice.Under the proposed settlement, the Lower Merion School District will pay $185,000 to two high school students who had sued the district earlier this year for allegedly snooping on them. The remaining $425,000 will go to attorneys fees. The proposed settlement was approved by the district’s school board of directors Monday. It results from a “lengthy, court-ordered mediation” between all concerned parties, board President David Ebby said in a statement. “Though we would have valued the opportunity to finally share an important, untold story in the courtroom, we recognize that in this case, a lengthy, costly trial would benefit no one,” Ebby noted. The statement did not elaborate on what untold story Ebby was referring to.The school district, in Ardmore, Pa., has been at the center of a huge controversy over its use of a specialized embedded software product for tracking stolen, lost or missing school-issued laptops. The district provided laptops to about 1,800 of its high school students, but it didn’t tell them about the embedded tracking software, which could be used to remotely activate webcams on the laptops.In February, Blake Robbins, a district high school student, and his parents, filed a lawsuit against the school district accusing it of spying on him in his home. The lawsuit charged Lower Merion with remotely activating the webcam on Robbins’ laptop to take thousands of pictures of Blake and others members of his family, including some of Blake in his bedroom partially undressed, and some of him sleeping.The lawsuit was filed after a school official accused Blake of selling drugs and taking pills based on a photograph captured by the school computer at his home. In court documents, lawyers for Blake accused Lower Merion officials of taking thousands of webcam photos and screenshots of numerous other students, many of whom had never reported their laptops as being missing or stolen.An investigation conducted on Our portfolio here is the broadest in the industry. Our priorities include seasonal infections, chronic infections, common childhood diseases and rarer but critical conditions like meningitis. We also focus on bacterial infections where resistance is creating an urgent need for new treatments. Our cultureCulture at GSK is something we all own. It powers our purpose, drives delivery of our strategy and helps make GSK a place where people can thrive. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we’ll deliver for patients, shareholders and GSK people.Our Code sets out the commitments GSK and our people make to get ahead together – so we can deliver on our ambition in the right way, bring our culture to life and make GSK an exciting and inspiring place to work. Innovating together Meet Nancy: igniting change & innovation for patients living with Respiratory Syncytial Virus Great place to work Meet Ram: an engineer, athlete and proud father, revolutionising vaccine manufacturing at GSK You might also like

Former GSK facility in Upper Merion becomes world's

Kalihokan kondili sa ilang mga stakeholder ug reputasyon.Dugang pa, ang GSK nanginahanglan usa ka solusyon nga hapsay nga mahiusa sa ilang mga naglungtad nga sistema ug proseso, nga wala magkinahanglan og daghang pagbansay o adunay taas nga pagmentinar costs.3. ang DataNumen Zip Repair solusyonDataNumen Zip Repair napamatud-an nga mao ang solusyon nga malampusong nakab-ot ang higpit nga mga kinahanglanon sa GSK. Ang software milabaw sa pag-ayo sa mga dunot zip mga file, sa ingon mapanalipdan ang integridad sa gitipigan nga datos. Ug uban ang labi ka intuitive nga interface ug kusog nga mga kapabilidad sa pagbawi, bisan ang most ang grabeng nadaot nga mga file mahimong dali ug episyente nga ayohon, pagsiguro nga gamay nga downtime alang sa mga operasyon sa GSK.Gawas pa sa pag-ayo sa problema, DataNumen Zip Repair nagtanyag usab og mga bahin sama sa pagproseso sa batch, pag-integrate sa Windows Explorer, ug ang abilidad sa pagtrabaho uban ang dagkong mga gidak-on sa file. Kining tanan gihimo DataNumen Zip Repair praktikal ug cost-Epektibo nga solusyon alang sa GSK.Sa ubos mao ang order (Advanced Zip Repair mao ang kanhi ngalan sa DataNumen Zip Repair):4. PagpatumanAng pagpatuman sa DataNumen Zip Repair sa mga sistema sa GSK usa ka paspas nga proseso. Uban sa pagkamahigalaon sa software sa software ug sa GSK nga may katakus kaayo nga IT team, ang tibuok kompanya andam ug andam sa paggamit sa plataporma sa mubo kaayo nga timeframe. Ang pagpatuman gihimo sa mga hugna, pagsiguro sa usa ka hapsay nga transisyon ug gamay nga pagkabalda sa mga operasyon sa GSK.5. Ang ResultaAng paggamit sa DataNumen Zip Repair niresulta sa dako kaayong benepisyo para sa GSK. Gigarantiyahan sa software ang integridad ug accessibility sa datos, nga nagdala ngadto sa mas dako nga episyente sa mga operasyon ug naghatag og kalinaw sa hunahuna mahitungod sa pagkawala sa datos o korapsyon. Dugang pa, ang GSK nakakuha og access sa maayo kaayo nga suporta sa serbisyo sa kustomer gikan sa DataNumen, nga moresulta sa paspas nga pagsulbad sa bisan unsang mga isyu nga nasugatan.6. PanaposSa konklusyon, ang kasinatian sa GSK sa DataNumen Zip Repair labi ka mapuslanon, nga nagpamatuod

Directions to the 'Upper Merion - West Campus' of GlaxoSmithKline (GSK):

Ang kaepektibo ug kalampusan sa daghang mga modernong negosyo nagsalig kaayo sa integridad ug pagka-access sa ilang digital data. Ang pagkawala o korapsyon sa maong mga datos mahimong mosangpot sa dakong pagkabalda o bisan pagkaguba sa mga proseso sa negosyo. Zip files, usa ka komon nga format alang sa data storage ug transmission, dili eksepsiyon sa potensyal nga korapsyon ug kadaot. Bisan pa, adunay usa ka kasaligan nga himan, sama sa DataNumen Zip Repair, makahimo og kalibutan sa kalainan.Usa ka Fortune Global 500 ug usa sa mga nanguna nga kompanya sa pag-atiman sa kahimsog sa kalibutan, ang GlaxoSmithKline (GSK), naggamit DataNumenni Zip Pag-ayo aron masiguro nga ang datos niini kanunay nga ma-access ug mapanalipdan gikan sa korapsyon - ang yawe sa nagpadayon nga kalampusan niini. Kini nga case study nagtutok sa paggamit sa GSK sa DataNumenang produkto ug ang mga depinitibo nga resulta niini.1. Overview sa GlaxoSmithKlineIsip usa ka kompanya sa pag-atiman sa kahimsog sa kalibutan nga gipangulohan sa siyensya, ang GSK nagtinguha nga mapauswag ang kalidad sa kinabuhi sa tawo pinaagi sa pagpaarang sa mga tawo nga makahimo pa, mobati nga labi ka maayo, ug mabuhi nga mas taas. Kini nga katuyoan nagtuyok sa pagpauswag sa epektibo nga mga produkto sa pag-atiman sa kahimsog, sama sa mga bakuna, tambal, ug mga produkto sa pag-atiman sa kahimsog sa mga konsumedor.Sa ingon nga usa ka lainlain ug kabag-ohan-driven nga palibot, ang GSK nagsalig pag-ayo sa mahinungdanong gidaghanon sa digital data, gikan sa mga rekord sa pasyente ngadto sa R&D nga impormasyon. Ang wala dayon, walay kasaypanan nga pag-access sa kini nga datos mahimo’g makabalda sa ilang mga operasyon, o labi pa, makadaot sa kahimsog sa ilang mga pasyente.2. Ang HagitAng nag-unang hagit nga giatubang sa GSK mao ang pagsiguro sa kaluwasan ug integridad sa ilang daghang mga kritikal nga datos nga gitipigan sa zip mga file. Uban sa zip Ang mga file nga prone sa korapsyon tungod sa lain-laing mga rason, ang wala mamatikdi nga risgo sa korapsyon alang sa datos sa GSK mahimong mosangpot sa usa ka dakong pagkabalda sa operasyon, nga makaapekto dili lamang sa ilang adlaw-adlaw nga mga. GSK’s Upper Merion facility is located on the Upper Merion East Campus. GSK sold its Upper Merion West campus to The Discovery Labs, which announced in a J press release that it is redeveloping the Upper Merion West Campus and a campus in King of Prussia into a coworking ecosystem for healthcare, life sciences, and technology Upper Merion, Pennsylvania, United States GSK Upper Merion, Pennsylvania, United States Equity and Inclusion initiatives at GSK. She scaled programs of work, introduced them to other sites

The Grateful Meds at the GSK Upper Merion site picnic

There are a number of ways you can manage your GSK shares. Please read on to find out more. You can manage your UK shares and request changes to your details on the Investor Centre (computershare.com).If you register with Computershare Investor Centre you will be able to make the following changes online:Change address detailsChange bank account details for dividend paymentsUpdate your communication preferenceJoin Reinvestment PlansSell your shares Your dividend paymentsIn April 2020 GSK simplified the way it makes dividend payments. All cash dividends are now only distributed by direct credit.You will need to provide Computershare, our registrar, with your bank details for your dividends to be paid directly to your nominated account by direct credit. If you do not provide this information, you will still receive an annual dividend statement; however, you will not receive the money until your bank details are received, after which payment will be credited to your bank or building society account as soon as possible. Your dividends will not accrue interest while they are being held for you and there may be a fee for Computershare to reissue payments.Please see our FAQs for further information on this change. Alternatively, you can contact Computershare directly. Their contact details can be found on the Investors contact details page. Reinvest your dividends to buy more sharesWith the GSK Dividend Reinvestment Plan (DRIP) you can use your cash dividends to buy more shares in GSK. As an alternative to the dividend payment, your cash will be used to buy additional shares. The DRIP is a convenient, easy and cost-effective way to build your shareholding.To apply for the GSK DRIP, visit the Investor Centre. US-based shareholdersUS-based shareholders should contact JP Morgan ADR shareholder services. Their contact details can be found on the Investors contact details page.The Depositary also provides Global